pharmaphorum13d
GSK's Nucala gains US use in rare autoimmune disease
GlaxoSmithKline’s Nucala (mepolizumab) has gained a new FDA approval for the rare autoimmune disease eosinophilic granulomatosis with polyangiitis (EGPA). Nucala, an interleukin-5 (IL-5 ...
Healthline16d
What Medications Help Treat Myasthenia Gravis?
Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...
GSK’s GSK’227 receives FDA BTD for treating adults with relapsed osteosarcoma
GSK (GSK) announced that the US Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, for GSK5764227, GSK’227, ...
Yahoo Finance19d
China’s NMPA approves GSK’s Nucala for CRSwNP treatment
The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with ...
Pharmaceutical Technology19d
China’s NMPA approves GSK’s Nucala for CRSwNP treatment
GSK’s Nucala was approved in the US for severe asthma with an eosinophilic phenotype treatment. Credit: MAXSHOT.PL / Shutterstock. The China National Medical Products Administration (NMPA) has ...
BioPharma Dive19d
5 FDA decisions to watch in the first quarter of 2025
Every presidential election brings change to the Food and Drug Administration. This time around, the upheaval could be particularly jarring. The nomination of Robert F. Kennedy Jr. to lead the ...
BioPharma Dive19d
Navigating future biopharma catalysts: What to expect at the 2025 J.P. Morgan Healthcare Conference
1. Innovative therapies and technologies: Expect spotlight sessions on the latest in gene editing, AI-driven diagnostics and novel drug delivery systems. While many presentation topics are not ...
La Crosse Tribune21d
Downtown fight leads to drug charge for La Crosse man
A disturbance in downtown La Crosse led to the arrest Dec. 22 of a 24-year-old La Crosse man on drug charges. Devante K. Riles was charged in La Crosse County Circuit Court with a felony count of ...
Pharmabiz21d
GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps
GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...
ENDPOINTS NEWS22d
Af­ter Ca­griSe­ma, eyes are on Lil­ly’s oral GLP-1 as next key obe­si­ty play
With the dis­ap­point­ment of No­vo Nordisk’s in­ject­ed Ca­griSe­ma in obe­si­ty at the end of 2024, ...
Business Insider22d
GSK’s Nucala Gains Approval in China for CRSwNP
Nucala (mepolizumab), has been approved in China for treating adults with chronic rhinosinusitis with nasal polyps (CRSwNP), a condition affecting 30 million people in the country. This approval ...
Daily Mail23d
Doctor reveals common medications taken by millions that can lead to a heart attack
A top doctor has revealed which common medications taken by millions could put you at risk of a heart attack. Dr Zain Hasan, an anesthetist in California, highlighted non-steroidal anti ...